Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Molecular Templates Inc (MTEM)

Molecular Templates Inc (MTEM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 501,658
  • Shares Outstanding, K 45,730
  • Annual Sales, $ 22,270 K
  • Annual Income, $ -69,420 K
  • 60-Month Beta 2.44
  • Price/Sales 23.68
  • Price/Cash Flow N/A
  • Price/Book 6.29

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.37
  • Number of Estimates 3
  • High Estimate -0.29
  • Low Estimate -0.46
  • Prior Year -0.25
  • Growth Rate Est. (year over year) -48.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.72 +5.04%
on 07/31/20
14.89 -24.38%
on 07/07/20
-2.25 (-16.65%)
since 07/02/20
3-Month
10.72 +5.04%
on 07/31/20
18.44 -38.94%
on 05/11/20
-4.28 (-27.54%)
since 05/01/20
52-Week
4.51 +149.67%
on 08/23/19
19.12 -41.12%
on 03/06/20
+4.77 (+73.50%)
since 08/02/19

Most Recent Stories

More News
Molecular Templates, Inc. Raises $43 Million in Gross Proceeds Through Its At-the-Market Facility

Molecular Templates, Inc. (Nasdaq: MTEM, "Molecular Templates," "MTEM" or the "Company"), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company's proprietary...

MTEM : 11.41 (+4.01%)
Molecular Templates' Presentations at the American Association of Cancer Research (AACR) Annual Meeting 2020 Highlight Evolution of ETB Platform

Update Provided Phase I Study of MT-5111 in HER2-positive Cancers

MTEM : 11.41 (+4.01%)
Molecular Templates, Inc. Announces $45 Million Debt Financing From K2 HealthVentures

Molecular Templates, Inc. (Nasdaq: MTEM, "Molecular Templates," "MTEM" or the "Company"), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company's proprietary...

MTEM : 11.41 (+4.01%)
New Data on Molecular Templates' Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Virtual Annual Meeting II

Molecular Templates, Inc. (Nasdaq: MTEM, "Molecular Templates," or "MTEM"), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company's proprietary targeted biologic...

MTEM : 11.41 (+4.01%)
Molecular Templates to Participate in Two May Virtual Investor Conferences

Molecular Templates, Inc. (Nasdaq: MTEM, "Molecular Templates" or "MTEM"), a clinical-stage biopharmaceutical company focused on the discovery and development of the company's proprietary engineered toxin...

MTEM : 11.41 (+4.01%)
Molecular Templates, Inc. Reports First Quarter 2020 Financial Results

Molecular Templates, Inc. (Nasdaq: MTEM, "Molecular Templates," or "MTEM"), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company's proprietary targeted biologic...

MTEM : 11.41 (+4.01%)
Molecular Templates, Inc. Announces that the 2020 Annual Meeting of Stockholders Will be Held in Virtual Format

Molecular Templates, Inc. (the "Company") (Nasdaq: MTEM) announced today that the 2020 Annual Meeting of Stockholders (the "Annual Meeting") will be held virtually due to the public health impact of the...

MTEM : 11.41 (+4.01%)
Will Molecular Templates Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor Molecular Templates

MTEM : 11.41 (+4.01%)
Catalyst's (CPRX) Q4 Earnings Miss Estimates, Revenues Meet

Catalyst's (CPRX) earnings lag estimates in the fourth quarter. Revenues match the same.

BCRX : 4.26 (+4.67%)
CPRX : 4.09 (-4.88%)
MTEM : 11.41 (+4.01%)
ORGO : 3.68 (-0.82%)
7 Great Stocks for a Small Budget

Take advantage of panic selling with these 7 cheap stocks.

BCRX : 4.26 (+4.67%)
CALX : 20.90 (+1.90%)
TRN : 19.75 (+1.13%)
SPN : 1.0400 (-4.59%)
OESX : 4.13 (+4.29%)
APAM : 37.42 (+3.28%)
MTEM : 11.41 (+4.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade MTEM with:

Business Summary

Molecular Templates Inc. is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies for the treatment of cancers and other serious diseases. Molecular Templates Inc., formerly known as Threshold Pharmaceuticals Inc., is headquartered...

See More

Key Turning Points

2nd Resistance Point 11.96
1st Resistance Point 11.47
Last Price 11.41
1st Support Level 10.60
2nd Support Level 10.22

See More

52-Week High 19.12
Fibonacci 61.8% 13.54
Fibonacci 50% 11.82
Last Price 11.41
Fibonacci 38.2% 10.09
52-Week Low 4.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar